BIO SB Renal Cell Carcinoma (PN-15), MMab
For In Vitro Diagnostic Use
Description
Renal Cell Carcinoma (RCC), also known as a Gurnistical Tumor, is the most common form of kidney cancer arising from the renal tubule. It is also the most common type of kidney cancer in adults. Initial treatment is surgery because it is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy. Renal Cell Carcinoma antibody (RCC) recognizes a 200 kDa glycoprotein localized in the brush border of the proximal renal tubule. This antibody immunoreacts with approximately 90% of Primary Renal Cell Carcinomas and approximately 85% of Metastatic Renal Cell Carcinomas. Other tumors that may react with this antibody are Parathyroid Adenoma, an occasional Breast Carcinoma. Nephroblastoma, Oncocytoma, Mesoblastic Nephroma, Transitional Cell Carcinoma, and Angiomyolipoma are not labeled with this antibody.
Synonymes
renal cell carcinoma, anti-renal cell carcinoma, rcc, anti-rcc, renel cell, renal call, anti-renel, anti rcc, renal cortical tissue, kidney cancer, renal adenocarcinoma
Caractéristiques
- Type
- Mouse Monoclonal
- Clone
- PN-15
- Isotype
- IgG1/K
- Réactivité
- Paraffin, Frozen
- Localisation
- Cytoplasmic, Membranous
- Contrôle
- Kidney, Breast, Thyroid, Renal Cell Carcinoma
- Usage prévu
- For In Vitro Diagnostic Use
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.